Pharma & Healthcare
Global TACE Embolic Microspheres Market Research Report 2026
- Feb 24, 26
- ID: 721371
- Pages: 112
- Figures: 109
- Views: 6
This report delivers a comprehensive overview of the global TACE Embolic Microspheres market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding TACE Embolic Microspheres. The TACE Embolic Microspheres market size, estimates, and forecasts are provided in terms of sales volume (L) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global TACE Embolic Microspheres market comprehensively. Regional market sizes by Type, by Application, by Size, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist TACE Embolic Microspheres manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Boston Scientific
Terumo
Merit Medical
Varian
Sirtex Medical
Suzhou Hengrui Medical Equipment
ABK Biomedical
Mermaid Medical
Cardiolink Science
Suzhou Haowei Medical Technology
Segment by Type
Common Embolic Microspheres
Drug-Loadable Embolic Microspheres
Segment by Size
1G (<100μm)
2 G (≥100μm)
by Application
Primary Liver Cancer
Colorectal Cancer Liver Metastasis
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Size, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for TACE Embolic Microspheres manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines TACE Embolic Microspheres sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global TACE Embolic Microspheres market comprehensively. Regional market sizes by Type, by Application, by Size, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist TACE Embolic Microspheres manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Boston Scientific
Terumo
Merit Medical
Varian
Sirtex Medical
Suzhou Hengrui Medical Equipment
ABK Biomedical
Mermaid Medical
Cardiolink Science
Suzhou Haowei Medical Technology
Segment by Type
Common Embolic Microspheres
Drug-Loadable Embolic Microspheres
Segment by Size
1G (<100μm)
2 G (≥100μm)
by Application
Primary Liver Cancer
Colorectal Cancer Liver Metastasis
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Size, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for TACE Embolic Microspheres manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines TACE Embolic Microspheres sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 TACE Embolic Microspheres Market Overview
1.1 Product Definition
1.2 TACE Embolic Microspheres by Type
1.2.1 Global TACE Embolic Microspheres Market Value by Type: 2025 vs 2032
1.2.2 Common Embolic Microspheres
1.2.3 Drug-Loadable Embolic Microspheres
1.3 TACE Embolic Microspheres by Size
1.3.1 Global TACE Embolic Microspheres Market Value by Size: 2025 vs 2032
1.3.2 1G (<100μm)
1.3.3 2 G (≥100μm)
1.4 TACE Embolic Microspheres by Application
1.4.1 Global TACE Embolic Microspheres Market Value by Application: 2025 vs 2032
1.4.2 Primary Liver Cancer
1.4.3 Colorectal Cancer Liver Metastasis
1.4.4 Others
1.5 Global TACE Embolic Microspheres Market Size Estimates and Forecasts
1.5.1 Global TACE Embolic Microspheres Revenue 2021–2032
1.5.2 Global TACE Embolic Microspheres Sales 2021–2032
1.5.3 Global TACE Embolic Microspheres Market Average Price (2021–2032)
1.6 Assumptions and Limitations
2 TACE Embolic Microspheres Market Competition by Manufacturers
2.1 Global TACE Embolic Microspheres Sales Market Share by Manufacturers (2021–2026)
2.2 Global TACE Embolic Microspheres Revenue Market Share by Manufacturers (2021–2026)
2.3 Global TACE Embolic Microspheres Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of TACE Embolic Microspheres, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of TACE Embolic Microspheres, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of TACE Embolic Microspheres, Product Types and Applications
2.7 Global Key Manufacturers of TACE Embolic Microspheres, Date of Entry into the Industry
2.8 Global TACE Embolic Microspheres Market Competitive Situation and Trends
2.8.1 Global TACE Embolic Microspheres Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global TACE Embolic Microspheres Players Market Share by Revenue
2.8.3 Global TACE Embolic Microspheres Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global TACE Embolic Microspheres Market Scenario by Region
3.1 Global TACE Embolic Microspheres Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global TACE Embolic Microspheres Sales by Region: 2021–2032
3.2.1 Global TACE Embolic Microspheres Sales by Region: 2021–2026
3.2.2 Global TACE Embolic Microspheres Sales by Region: 2027–2032
3.3 Global TACE Embolic Microspheres Revenue by Region: 2021–2032
3.3.1 Global TACE Embolic Microspheres Revenue by Region: 2021–2026
3.3.2 Global TACE Embolic Microspheres Revenue by Region: 2027–2032
3.4 North America TACE Embolic Microspheres Market Facts & Figures by Country
3.4.1 North America TACE Embolic Microspheres Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America TACE Embolic Microspheres Sales by Country (2021–2032)
3.4.3 North America TACE Embolic Microspheres Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe TACE Embolic Microspheres Market Facts & Figures by Country
3.5.1 Europe TACE Embolic Microspheres Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe TACE Embolic Microspheres Sales by Country (2021–2032)
3.5.3 Europe TACE Embolic Microspheres Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific TACE Embolic Microspheres Market Facts & Figures by Region
3.6.1 Asia Pacific TACE Embolic Microspheres Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific TACE Embolic Microspheres Sales by Region (2021–2032)
3.6.3 Asia Pacific TACE Embolic Microspheres Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America TACE Embolic Microspheres Market Facts & Figures by Country
3.7.1 Latin America TACE Embolic Microspheres Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America TACE Embolic Microspheres Sales by Country (2021–2032)
3.7.3 Latin America TACE Embolic Microspheres Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa TACE Embolic Microspheres Market Facts & Figures by Country
3.8.1 Middle East and Africa TACE Embolic Microspheres Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa TACE Embolic Microspheres Sales by Country (2021–2032)
3.8.3 Middle East and Africa TACE Embolic Microspheres Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global TACE Embolic Microspheres Sales by Type (2021–2032)
4.1.1 Global TACE Embolic Microspheres Sales by Type (2021–2026)
4.1.2 Global TACE Embolic Microspheres Sales by Type (2027–2032)
4.1.3 Global TACE Embolic Microspheres Sales Market Share by Type (2021–2032)
4.2 Global TACE Embolic Microspheres Revenue by Type (2021–2032)
4.2.1 Global TACE Embolic Microspheres Revenue by Type (2021–2026)
4.2.2 Global TACE Embolic Microspheres Revenue by Type (2027–2032)
4.2.3 Global TACE Embolic Microspheres Revenue Market Share by Type (2021–2032)
4.3 Global TACE Embolic Microspheres Price by Type (2021–2032)
5 Segment by Application
5.1 Global TACE Embolic Microspheres Sales by Application (2021–2032)
5.1.1 Global TACE Embolic Microspheres Sales by Application (2021–2026)
5.1.2 Global TACE Embolic Microspheres Sales by Application (2027–2032)
5.1.3 Global TACE Embolic Microspheres Sales Market Share by Application (2021–2032)
5.2 Global TACE Embolic Microspheres Revenue by Application (2021–2032)
5.2.1 Global TACE Embolic Microspheres Revenue by Application (2021–2026)
5.2.2 Global TACE Embolic Microspheres Revenue by Application (2027–2032)
5.2.3 Global TACE Embolic Microspheres Revenue Market Share by Application (2021–2032)
5.3 Global TACE Embolic Microspheres Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Boston Scientific
6.1.1 Boston Scientific Company Information
6.1.2 Boston Scientific Description and Business Overview
6.1.3 Boston Scientific TACE Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Boston Scientific TACE Embolic Microspheres Product Portfolio
6.1.5 Boston Scientific Recent Developments/Updates
6.2 Terumo
6.2.1 Terumo Company Information
6.2.2 Terumo Description and Business Overview
6.2.3 Terumo TACE Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Terumo TACE Embolic Microspheres Product Portfolio
6.2.5 Terumo Recent Developments/Updates
6.3 Merit Medical
6.3.1 Merit Medical Company Information
6.3.2 Merit Medical Description and Business Overview
6.3.3 Merit Medical TACE Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Merit Medical TACE Embolic Microspheres Product Portfolio
6.3.5 Merit Medical Recent Developments/Updates
6.4 Varian
6.4.1 Varian Company Information
6.4.2 Varian Description and Business Overview
6.4.3 Varian TACE Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Varian TACE Embolic Microspheres Product Portfolio
6.4.5 Varian Recent Developments/Updates
6.5 Sirtex Medical
6.5.1 Sirtex Medical Company Information
6.5.2 Sirtex Medical Description and Business Overview
6.5.3 Sirtex Medical TACE Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Sirtex Medical TACE Embolic Microspheres Product Portfolio
6.5.5 Sirtex Medical Recent Developments/Updates
6.6 Suzhou Hengrui Medical Equipment
6.6.1 Suzhou Hengrui Medical Equipment Company Information
6.6.2 Suzhou Hengrui Medical Equipment Description and Business Overview
6.6.3 Suzhou Hengrui Medical Equipment TACE Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Suzhou Hengrui Medical Equipment TACE Embolic Microspheres Product Portfolio
6.6.5 Suzhou Hengrui Medical Equipment Recent Developments/Updates
6.7 ABK Biomedical
6.7.1 ABK Biomedical Company Information
6.7.2 ABK Biomedical Description and Business Overview
6.7.3 ABK Biomedical TACE Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 ABK Biomedical TACE Embolic Microspheres Product Portfolio
6.7.5 ABK Biomedical Recent Developments/Updates
6.8 Mermaid Medical
6.8.1 Mermaid Medical Company Information
6.8.2 Mermaid Medical Description and Business Overview
6.8.3 Mermaid Medical TACE Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Mermaid Medical TACE Embolic Microspheres Product Portfolio
6.8.5 Mermaid Medical Recent Developments/Updates
6.9 Cardiolink Science
6.9.1 Cardiolink Science Company Information
6.9.2 Cardiolink Science Description and Business Overview
6.9.3 Cardiolink Science TACE Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Cardiolink Science TACE Embolic Microspheres Product Portfolio
6.9.5 Cardiolink Science Recent Developments/Updates
6.10 Suzhou Haowei Medical Technology
6.10.1 Suzhou Haowei Medical Technology Company Information
6.10.2 Suzhou Haowei Medical Technology Description and Business Overview
6.10.3 Suzhou Haowei Medical Technology TACE Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Suzhou Haowei Medical Technology TACE Embolic Microspheres Product Portfolio
6.10.5 Suzhou Haowei Medical Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 TACE Embolic Microspheres Industry Chain Analysis
7.2 TACE Embolic Microspheres Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 TACE Embolic Microspheres Production Mode & Process Analysis
7.4 TACE Embolic Microspheres Sales and Marketing
7.4.1 TACE Embolic Microspheres Sales Channels
7.4.2 TACE Embolic Microspheres Distributors
7.5 TACE Embolic Microspheres Customer Analysis
8 TACE Embolic Microspheres Market Dynamics
8.1 TACE Embolic Microspheres Industry Trends
8.2 TACE Embolic Microspheres Market Drivers
8.3 TACE Embolic Microspheres Market Challenges
8.4 TACE Embolic Microspheres Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 TACE Embolic Microspheres by Type
1.2.1 Global TACE Embolic Microspheres Market Value by Type: 2025 vs 2032
1.2.2 Common Embolic Microspheres
1.2.3 Drug-Loadable Embolic Microspheres
1.3 TACE Embolic Microspheres by Size
1.3.1 Global TACE Embolic Microspheres Market Value by Size: 2025 vs 2032
1.3.2 1G (<100μm)
1.3.3 2 G (≥100μm)
1.4 TACE Embolic Microspheres by Application
1.4.1 Global TACE Embolic Microspheres Market Value by Application: 2025 vs 2032
1.4.2 Primary Liver Cancer
1.4.3 Colorectal Cancer Liver Metastasis
1.4.4 Others
1.5 Global TACE Embolic Microspheres Market Size Estimates and Forecasts
1.5.1 Global TACE Embolic Microspheres Revenue 2021–2032
1.5.2 Global TACE Embolic Microspheres Sales 2021–2032
1.5.3 Global TACE Embolic Microspheres Market Average Price (2021–2032)
1.6 Assumptions and Limitations
2 TACE Embolic Microspheres Market Competition by Manufacturers
2.1 Global TACE Embolic Microspheres Sales Market Share by Manufacturers (2021–2026)
2.2 Global TACE Embolic Microspheres Revenue Market Share by Manufacturers (2021–2026)
2.3 Global TACE Embolic Microspheres Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of TACE Embolic Microspheres, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of TACE Embolic Microspheres, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of TACE Embolic Microspheres, Product Types and Applications
2.7 Global Key Manufacturers of TACE Embolic Microspheres, Date of Entry into the Industry
2.8 Global TACE Embolic Microspheres Market Competitive Situation and Trends
2.8.1 Global TACE Embolic Microspheres Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global TACE Embolic Microspheres Players Market Share by Revenue
2.8.3 Global TACE Embolic Microspheres Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global TACE Embolic Microspheres Market Scenario by Region
3.1 Global TACE Embolic Microspheres Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global TACE Embolic Microspheres Sales by Region: 2021–2032
3.2.1 Global TACE Embolic Microspheres Sales by Region: 2021–2026
3.2.2 Global TACE Embolic Microspheres Sales by Region: 2027–2032
3.3 Global TACE Embolic Microspheres Revenue by Region: 2021–2032
3.3.1 Global TACE Embolic Microspheres Revenue by Region: 2021–2026
3.3.2 Global TACE Embolic Microspheres Revenue by Region: 2027–2032
3.4 North America TACE Embolic Microspheres Market Facts & Figures by Country
3.4.1 North America TACE Embolic Microspheres Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America TACE Embolic Microspheres Sales by Country (2021–2032)
3.4.3 North America TACE Embolic Microspheres Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe TACE Embolic Microspheres Market Facts & Figures by Country
3.5.1 Europe TACE Embolic Microspheres Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe TACE Embolic Microspheres Sales by Country (2021–2032)
3.5.3 Europe TACE Embolic Microspheres Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific TACE Embolic Microspheres Market Facts & Figures by Region
3.6.1 Asia Pacific TACE Embolic Microspheres Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific TACE Embolic Microspheres Sales by Region (2021–2032)
3.6.3 Asia Pacific TACE Embolic Microspheres Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America TACE Embolic Microspheres Market Facts & Figures by Country
3.7.1 Latin America TACE Embolic Microspheres Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America TACE Embolic Microspheres Sales by Country (2021–2032)
3.7.3 Latin America TACE Embolic Microspheres Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa TACE Embolic Microspheres Market Facts & Figures by Country
3.8.1 Middle East and Africa TACE Embolic Microspheres Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa TACE Embolic Microspheres Sales by Country (2021–2032)
3.8.3 Middle East and Africa TACE Embolic Microspheres Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global TACE Embolic Microspheres Sales by Type (2021–2032)
4.1.1 Global TACE Embolic Microspheres Sales by Type (2021–2026)
4.1.2 Global TACE Embolic Microspheres Sales by Type (2027–2032)
4.1.3 Global TACE Embolic Microspheres Sales Market Share by Type (2021–2032)
4.2 Global TACE Embolic Microspheres Revenue by Type (2021–2032)
4.2.1 Global TACE Embolic Microspheres Revenue by Type (2021–2026)
4.2.2 Global TACE Embolic Microspheres Revenue by Type (2027–2032)
4.2.3 Global TACE Embolic Microspheres Revenue Market Share by Type (2021–2032)
4.3 Global TACE Embolic Microspheres Price by Type (2021–2032)
5 Segment by Application
5.1 Global TACE Embolic Microspheres Sales by Application (2021–2032)
5.1.1 Global TACE Embolic Microspheres Sales by Application (2021–2026)
5.1.2 Global TACE Embolic Microspheres Sales by Application (2027–2032)
5.1.3 Global TACE Embolic Microspheres Sales Market Share by Application (2021–2032)
5.2 Global TACE Embolic Microspheres Revenue by Application (2021–2032)
5.2.1 Global TACE Embolic Microspheres Revenue by Application (2021–2026)
5.2.2 Global TACE Embolic Microspheres Revenue by Application (2027–2032)
5.2.3 Global TACE Embolic Microspheres Revenue Market Share by Application (2021–2032)
5.3 Global TACE Embolic Microspheres Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Boston Scientific
6.1.1 Boston Scientific Company Information
6.1.2 Boston Scientific Description and Business Overview
6.1.3 Boston Scientific TACE Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Boston Scientific TACE Embolic Microspheres Product Portfolio
6.1.5 Boston Scientific Recent Developments/Updates
6.2 Terumo
6.2.1 Terumo Company Information
6.2.2 Terumo Description and Business Overview
6.2.3 Terumo TACE Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Terumo TACE Embolic Microspheres Product Portfolio
6.2.5 Terumo Recent Developments/Updates
6.3 Merit Medical
6.3.1 Merit Medical Company Information
6.3.2 Merit Medical Description and Business Overview
6.3.3 Merit Medical TACE Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Merit Medical TACE Embolic Microspheres Product Portfolio
6.3.5 Merit Medical Recent Developments/Updates
6.4 Varian
6.4.1 Varian Company Information
6.4.2 Varian Description and Business Overview
6.4.3 Varian TACE Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Varian TACE Embolic Microspheres Product Portfolio
6.4.5 Varian Recent Developments/Updates
6.5 Sirtex Medical
6.5.1 Sirtex Medical Company Information
6.5.2 Sirtex Medical Description and Business Overview
6.5.3 Sirtex Medical TACE Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Sirtex Medical TACE Embolic Microspheres Product Portfolio
6.5.5 Sirtex Medical Recent Developments/Updates
6.6 Suzhou Hengrui Medical Equipment
6.6.1 Suzhou Hengrui Medical Equipment Company Information
6.6.2 Suzhou Hengrui Medical Equipment Description and Business Overview
6.6.3 Suzhou Hengrui Medical Equipment TACE Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Suzhou Hengrui Medical Equipment TACE Embolic Microspheres Product Portfolio
6.6.5 Suzhou Hengrui Medical Equipment Recent Developments/Updates
6.7 ABK Biomedical
6.7.1 ABK Biomedical Company Information
6.7.2 ABK Biomedical Description and Business Overview
6.7.3 ABK Biomedical TACE Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 ABK Biomedical TACE Embolic Microspheres Product Portfolio
6.7.5 ABK Biomedical Recent Developments/Updates
6.8 Mermaid Medical
6.8.1 Mermaid Medical Company Information
6.8.2 Mermaid Medical Description and Business Overview
6.8.3 Mermaid Medical TACE Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Mermaid Medical TACE Embolic Microspheres Product Portfolio
6.8.5 Mermaid Medical Recent Developments/Updates
6.9 Cardiolink Science
6.9.1 Cardiolink Science Company Information
6.9.2 Cardiolink Science Description and Business Overview
6.9.3 Cardiolink Science TACE Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Cardiolink Science TACE Embolic Microspheres Product Portfolio
6.9.5 Cardiolink Science Recent Developments/Updates
6.10 Suzhou Haowei Medical Technology
6.10.1 Suzhou Haowei Medical Technology Company Information
6.10.2 Suzhou Haowei Medical Technology Description and Business Overview
6.10.3 Suzhou Haowei Medical Technology TACE Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Suzhou Haowei Medical Technology TACE Embolic Microspheres Product Portfolio
6.10.5 Suzhou Haowei Medical Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 TACE Embolic Microspheres Industry Chain Analysis
7.2 TACE Embolic Microspheres Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 TACE Embolic Microspheres Production Mode & Process Analysis
7.4 TACE Embolic Microspheres Sales and Marketing
7.4.1 TACE Embolic Microspheres Sales Channels
7.4.2 TACE Embolic Microspheres Distributors
7.5 TACE Embolic Microspheres Customer Analysis
8 TACE Embolic Microspheres Market Dynamics
8.1 TACE Embolic Microspheres Industry Trends
8.2 TACE Embolic Microspheres Market Drivers
8.3 TACE Embolic Microspheres Market Challenges
8.4 TACE Embolic Microspheres Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global TACE Embolic Microspheres Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global TACE Embolic Microspheres Market Value by Size (US$ Million), 2025 vs 2032
Table 3. Global TACE Embolic Microspheres Market Value by Application (US$ Million), 2025 vs 2032
Table 4. Global TACE Embolic Microspheres Market Competitive Situation by Manufacturers in 2025
Table 5. Global TACE Embolic Microspheres Sales (L) of Key Manufacturers (2021–2026)
Table 6. Global TACE Embolic Microspheres Sales Market Share by Manufacturers (2021–2026)
Table 7. Global TACE Embolic Microspheres Revenue (US$ Million) by Manufacturers (2021–2026)
Table 8. Global TACE Embolic Microspheres Revenue Share by Manufacturers (2021–2026)
Table 9. Global Market TACE Embolic Microspheres Average Price (US$/mL) of Key Manufacturers (2021–2026)
Table 10. Global Key Players of TACE Embolic Microspheres, Industry Ranking, 2023 vs 2024 vs 2025
Table 11. Global Key Manufacturers of TACE Embolic Microspheres, Manufacturing Sites and Headquarters
Table 12. Global Key Manufacturers of TACE Embolic Microspheres, Product Types and Applications
Table 13. Global Key Manufacturers of TACE Embolic Microspheres, Date of Entry into the Industry
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global TACE Embolic Microspheres Companies by Tier (Tier 1, Tier 2, Tier 3), based on TACE Embolic Microspheres Revenue, 2025
Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 17. Global TACE Embolic Microspheres Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 18. Global TACE Embolic Microspheres Sales by Region (L), 2021–2026
Table 19. Global TACE Embolic Microspheres Sales Market Share by Region (2021–2026)
Table 20. Global TACE Embolic Microspheres Sales by Region (L), 2027–2032
Table 21. Global TACE Embolic Microspheres Sales Market Share by Region (2027–2032)
Table 22. Global TACE Embolic Microspheres Revenue by Region (US$ Million), 2021–2026
Table 23. Global TACE Embolic Microspheres Revenue Market Share by Region (2021–2026)
Table 24. Global TACE Embolic Microspheres Revenue by Region (US$ Million), 2027–2032
Table 25. Global TACE Embolic Microspheres Revenue Market Share by Region (2027–2032)
Table 26. North America TACE Embolic Microspheres Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 27. North America TACE Embolic Microspheres Sales by Country (L), 2021–2026
Table 28. North America TACE Embolic Microspheres Sales by Country (L), 2027–2032
Table 29. North America TACE Embolic Microspheres Revenue by Country (US$ Million), 2021–2026
Table 30. North America TACE Embolic Microspheres Revenue by Country (US$ Million), 2027–2032
Table 31. Europe TACE Embolic Microspheres Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 32. Europe TACE Embolic Microspheres Sales by Country (L), 2021–2026
Table 33. Europe TACE Embolic Microspheres Sales by Country (L), 2027–2032
Table 34. Europe TACE Embolic Microspheres Revenue by Country (US$ Million), 2021–2026
Table 35. Europe TACE Embolic Microspheres Revenue by Country (US$ Million), 2027–2032
Table 36. Asia Pacific TACE Embolic Microspheres Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 37. Asia Pacific TACE Embolic Microspheres Sales by Region (L), 2021–2026
Table 38. Asia Pacific TACE Embolic Microspheres Sales by Region (L), 2027–2032
Table 39. Asia Pacific TACE Embolic Microspheres Revenue by Region (US$ Million), 2021–2026
Table 40. Asia Pacific TACE Embolic Microspheres Revenue by Region (US$ Million), 2027–2032
Table 41. Latin America TACE Embolic Microspheres Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 42. Latin America TACE Embolic Microspheres Sales by Country (L), 2021–2026
Table 43. Latin America TACE Embolic Microspheres Sales by Country (L), 2027–2032
Table 44. Latin America TACE Embolic Microspheres Revenue by Country (US$ Million), 2021–2026
Table 45. Latin America TACE Embolic Microspheres Revenue by Country (US$ Million), 2027–2032
Table 46. Middle East and Africa TACE Embolic Microspheres Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 47. Middle East and Africa TACE Embolic Microspheres Sales by Country (L), 2021–2026
Table 48. Middle East and Africa TACE Embolic Microspheres Sales by Country (L), 2027–2032
Table 49. Middle East and Africa TACE Embolic Microspheres Revenue by Country (US$ Million), 2021–2026
Table 50. Middle East and Africa TACE Embolic Microspheres Revenue by Country (US$ Million), 2027–2032
Table 51. Global TACE Embolic Microspheres Sales (L) by Type (2021–2026)
Table 52. Global TACE Embolic Microspheres Sales (L) by Type (2027–2032)
Table 53. Global TACE Embolic Microspheres Sales Market Share by Type (2021–2026)
Table 54. Global TACE Embolic Microspheres Sales Market Share by Type (2027–2032)
Table 55. Global TACE Embolic Microspheres Revenue (US$ Million) by Type (2021–2026)
Table 56. Global TACE Embolic Microspheres Revenue (US$ Million) by Type (2027–2032)
Table 57. Global TACE Embolic Microspheres Revenue Market Share by Type (2021–2026)
Table 58. Global TACE Embolic Microspheres Revenue Market Share by Type (2027–2032)
Table 59. Global TACE Embolic Microspheres Price (US$/mL) by Type (2021–2026)
Table 60. Global TACE Embolic Microspheres Price (US$/mL) by Type (2027–2032)
Table 61. Global TACE Embolic Microspheres Sales (L) by Application (2021–2026)
Table 62. Global TACE Embolic Microspheres Sales (L) by Application (2027–2032)
Table 63. Global TACE Embolic Microspheres Sales Market Share by Application (2021–2026)
Table 64. Global TACE Embolic Microspheres Sales Market Share by Application (2027–2032)
Table 65. Global TACE Embolic Microspheres Revenue (US$ Million) by Application (2021–2026)
Table 66. Global TACE Embolic Microspheres Revenue (US$ Million) by Application (2027–2032)
Table 67. Global TACE Embolic Microspheres Revenue Market Share by Application (2021–2026)
Table 68. Global TACE Embolic Microspheres Revenue Market Share by Application (2027–2032)
Table 69. Global TACE Embolic Microspheres Price (US$/mL) by Application (2021–2026)
Table 70. Global TACE Embolic Microspheres Price (US$/mL) by Application (2027–2032)
Table 71. Boston Scientific Company Information
Table 72. Boston Scientific Description and Business Overview
Table 73. Boston Scientific TACE Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 74. Boston Scientific TACE Embolic Microspheres Product
Table 75. Boston Scientific Recent Developments/Updates
Table 76. Terumo Company Information
Table 77. Terumo Description and Business Overview
Table 78. Terumo TACE Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 79. Terumo TACE Embolic Microspheres Product
Table 80. Terumo Recent Developments/Updates
Table 81. Merit Medical Company Information
Table 82. Merit Medical Description and Business Overview
Table 83. Merit Medical TACE Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 84. Merit Medical TACE Embolic Microspheres Product
Table 85. Merit Medical Recent Developments/Updates
Table 86. Varian Company Information
Table 87. Varian Description and Business Overview
Table 88. Varian TACE Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 89. Varian TACE Embolic Microspheres Product
Table 90. Varian Recent Developments/Updates
Table 91. Sirtex Medical Company Information
Table 92. Sirtex Medical Description and Business Overview
Table 93. Sirtex Medical TACE Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 94. Sirtex Medical TACE Embolic Microspheres Product
Table 95. Sirtex Medical Recent Developments/Updates
Table 96. Suzhou Hengrui Medical Equipment Company Information
Table 97. Suzhou Hengrui Medical Equipment Description and Business Overview
Table 98. Suzhou Hengrui Medical Equipment TACE Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 99. Suzhou Hengrui Medical Equipment TACE Embolic Microspheres Product
Table 100. Suzhou Hengrui Medical Equipment Recent Developments/Updates
Table 101. ABK Biomedical Company Information
Table 102. ABK Biomedical Description and Business Overview
Table 103. ABK Biomedical TACE Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 104. ABK Biomedical TACE Embolic Microspheres Product
Table 105. ABK Biomedical Recent Developments/Updates
Table 106. Mermaid Medical Company Information
Table 107. Mermaid Medical Description and Business Overview
Table 108. Mermaid Medical TACE Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 109. Mermaid Medical TACE Embolic Microspheres Product
Table 110. Mermaid Medical Recent Developments/Updates
Table 111. Cardiolink Science Company Information
Table 112. Cardiolink Science Description and Business Overview
Table 113. Cardiolink Science TACE Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 114. Cardiolink Science TACE Embolic Microspheres Product
Table 115. Cardiolink Science Recent Developments/Updates
Table 116. Suzhou Haowei Medical Technology Company Information
Table 117. Suzhou Haowei Medical Technology Description and Business Overview
Table 118. Suzhou Haowei Medical Technology TACE Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 119. Suzhou Haowei Medical Technology TACE Embolic Microspheres Product
Table 120. Suzhou Haowei Medical Technology Recent Developments/Updates
Table 121. Key Raw Materials Lists
Table 122. Raw Materials Key Suppliers Lists
Table 123. TACE Embolic Microspheres Distributors List
Table 124. TACE Embolic Microspheres Customers List
Table 125. TACE Embolic Microspheres Market Trends
Table 126. TACE Embolic Microspheres Market Drivers
Table 127. TACE Embolic Microspheres Market Challenges
Table 128. TACE Embolic Microspheres Market Restraints
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
Table 132. Authors List of This Report
List of Figures
Figure 1. Product Picture of TACE Embolic Microspheres
Figure 2. Global TACE Embolic Microspheres Market Value by Type (US$ Million), 2021–2032
Figure 3. Global TACE Embolic Microspheres Market Share by Type: 2025 & 2032
Figure 4. Common Embolic Microspheres Product Picture
Figure 5. Drug-Loadable Embolic Microspheres Product Picture
Figure 6. Global TACE Embolic Microspheres Market Value by Size (US$ Million), 2021–2032
Figure 7. Global TACE Embolic Microspheres Market Share by Size: 2025 vs 2032
Figure 8. 1G (<100μm) Product Picture
Figure 9. 2 G (≥100μm) Product Picture
Figure 10. Global TACE Embolic Microspheres Market Value by Application (US$ Million), 2021–2032
Figure 11. Global TACE Embolic Microspheres Market Share by Application: 2025 & 2032
Figure 12. Primary Liver Cancer
Figure 13. Colorectal Cancer Liver Metastasis
Figure 14. Others
Figure 15. Global TACE Embolic Microspheres Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global TACE Embolic Microspheres Market Size (US$ Million), 2021–2032
Figure 17. Global TACE Embolic Microspheres Sales (L), 2021–2032
Figure 18. Global TACE Embolic Microspheres Average Price (US$/mL), 2021–2032
Figure 19. TACE Embolic Microspheres Report Years Considered
Figure 20. TACE Embolic Microspheres Sales Share by Manufacturers in 2025
Figure 21. Global TACE Embolic Microspheres Revenue Share by Manufacturers in 2025
Figure 22. Top 5 and Top 10 Global TACE Embolic Microspheres Players: Market Share by Revenue in TACE Embolic Microspheres in 2025
Figure 23. TACE Embolic Microspheres Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 24. Global TACE Embolic Microspheres Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 25. North America TACE Embolic Microspheres Sales Market Share by Country (2021–2032)
Figure 26. North America TACE Embolic Microspheres Revenue Market Share by Country (2021–2032)
Figure 27. United States TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Canada TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Europe TACE Embolic Microspheres Sales Market Share by Country (2021–2032)
Figure 30. Europe TACE Embolic Microspheres Revenue Market Share by Country (2021–2032)
Figure 31. Germany TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. France TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. U.K. TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Italy TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Russia TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Asia Pacific TACE Embolic Microspheres Sales Market Share by Region (2021–2032)
Figure 37. Asia Pacific TACE Embolic Microspheres Revenue Market Share by Region (2021–2032)
Figure 38. China TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Japan TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. South Korea TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. India TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Australia TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. China Taiwan TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Southeast Asia TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Latin America TACE Embolic Microspheres Sales Market Share by Country (2021–2032)
Figure 46. Latin America TACE Embolic Microspheres Revenue Market Share by Country (2021–2032)
Figure 47. Mexico TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Brazil TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Argentina TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Colombia TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Middle East and Africa TACE Embolic Microspheres Sales Market Share by Country (2021–2032)
Figure 52. Middle East and Africa TACE Embolic Microspheres Revenue Market Share by Country (2021–2032)
Figure 53. Turkey TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Saudi Arabia TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. UAE TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Global Sales Market Share of TACE Embolic Microspheres by Type (2021–2032)
Figure 57. Global Revenue Market Share of TACE Embolic Microspheres by Type (2021–2032)
Figure 58. Global TACE Embolic Microspheres Price (US$/mL) by Type (2021–2032)
Figure 59. Global Sales Market Share of TACE Embolic Microspheres by Application (2021–2032)
Figure 60. Global Revenue Market Share of TACE Embolic Microspheres by Application (2021–2032)
Figure 61. Global TACE Embolic Microspheres Price (US$/mL) by Application (2021–2032)
Figure 62. TACE Embolic Microspheres Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Global TACE Embolic Microspheres Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global TACE Embolic Microspheres Market Value by Size (US$ Million), 2025 vs 2032
Table 3. Global TACE Embolic Microspheres Market Value by Application (US$ Million), 2025 vs 2032
Table 4. Global TACE Embolic Microspheres Market Competitive Situation by Manufacturers in 2025
Table 5. Global TACE Embolic Microspheres Sales (L) of Key Manufacturers (2021–2026)
Table 6. Global TACE Embolic Microspheres Sales Market Share by Manufacturers (2021–2026)
Table 7. Global TACE Embolic Microspheres Revenue (US$ Million) by Manufacturers (2021–2026)
Table 8. Global TACE Embolic Microspheres Revenue Share by Manufacturers (2021–2026)
Table 9. Global Market TACE Embolic Microspheres Average Price (US$/mL) of Key Manufacturers (2021–2026)
Table 10. Global Key Players of TACE Embolic Microspheres, Industry Ranking, 2023 vs 2024 vs 2025
Table 11. Global Key Manufacturers of TACE Embolic Microspheres, Manufacturing Sites and Headquarters
Table 12. Global Key Manufacturers of TACE Embolic Microspheres, Product Types and Applications
Table 13. Global Key Manufacturers of TACE Embolic Microspheres, Date of Entry into the Industry
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global TACE Embolic Microspheres Companies by Tier (Tier 1, Tier 2, Tier 3), based on TACE Embolic Microspheres Revenue, 2025
Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 17. Global TACE Embolic Microspheres Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 18. Global TACE Embolic Microspheres Sales by Region (L), 2021–2026
Table 19. Global TACE Embolic Microspheres Sales Market Share by Region (2021–2026)
Table 20. Global TACE Embolic Microspheres Sales by Region (L), 2027–2032
Table 21. Global TACE Embolic Microspheres Sales Market Share by Region (2027–2032)
Table 22. Global TACE Embolic Microspheres Revenue by Region (US$ Million), 2021–2026
Table 23. Global TACE Embolic Microspheres Revenue Market Share by Region (2021–2026)
Table 24. Global TACE Embolic Microspheres Revenue by Region (US$ Million), 2027–2032
Table 25. Global TACE Embolic Microspheres Revenue Market Share by Region (2027–2032)
Table 26. North America TACE Embolic Microspheres Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 27. North America TACE Embolic Microspheres Sales by Country (L), 2021–2026
Table 28. North America TACE Embolic Microspheres Sales by Country (L), 2027–2032
Table 29. North America TACE Embolic Microspheres Revenue by Country (US$ Million), 2021–2026
Table 30. North America TACE Embolic Microspheres Revenue by Country (US$ Million), 2027–2032
Table 31. Europe TACE Embolic Microspheres Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 32. Europe TACE Embolic Microspheres Sales by Country (L), 2021–2026
Table 33. Europe TACE Embolic Microspheres Sales by Country (L), 2027–2032
Table 34. Europe TACE Embolic Microspheres Revenue by Country (US$ Million), 2021–2026
Table 35. Europe TACE Embolic Microspheres Revenue by Country (US$ Million), 2027–2032
Table 36. Asia Pacific TACE Embolic Microspheres Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 37. Asia Pacific TACE Embolic Microspheres Sales by Region (L), 2021–2026
Table 38. Asia Pacific TACE Embolic Microspheres Sales by Region (L), 2027–2032
Table 39. Asia Pacific TACE Embolic Microspheres Revenue by Region (US$ Million), 2021–2026
Table 40. Asia Pacific TACE Embolic Microspheres Revenue by Region (US$ Million), 2027–2032
Table 41. Latin America TACE Embolic Microspheres Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 42. Latin America TACE Embolic Microspheres Sales by Country (L), 2021–2026
Table 43. Latin America TACE Embolic Microspheres Sales by Country (L), 2027–2032
Table 44. Latin America TACE Embolic Microspheres Revenue by Country (US$ Million), 2021–2026
Table 45. Latin America TACE Embolic Microspheres Revenue by Country (US$ Million), 2027–2032
Table 46. Middle East and Africa TACE Embolic Microspheres Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 47. Middle East and Africa TACE Embolic Microspheres Sales by Country (L), 2021–2026
Table 48. Middle East and Africa TACE Embolic Microspheres Sales by Country (L), 2027–2032
Table 49. Middle East and Africa TACE Embolic Microspheres Revenue by Country (US$ Million), 2021–2026
Table 50. Middle East and Africa TACE Embolic Microspheres Revenue by Country (US$ Million), 2027–2032
Table 51. Global TACE Embolic Microspheres Sales (L) by Type (2021–2026)
Table 52. Global TACE Embolic Microspheres Sales (L) by Type (2027–2032)
Table 53. Global TACE Embolic Microspheres Sales Market Share by Type (2021–2026)
Table 54. Global TACE Embolic Microspheres Sales Market Share by Type (2027–2032)
Table 55. Global TACE Embolic Microspheres Revenue (US$ Million) by Type (2021–2026)
Table 56. Global TACE Embolic Microspheres Revenue (US$ Million) by Type (2027–2032)
Table 57. Global TACE Embolic Microspheres Revenue Market Share by Type (2021–2026)
Table 58. Global TACE Embolic Microspheres Revenue Market Share by Type (2027–2032)
Table 59. Global TACE Embolic Microspheres Price (US$/mL) by Type (2021–2026)
Table 60. Global TACE Embolic Microspheres Price (US$/mL) by Type (2027–2032)
Table 61. Global TACE Embolic Microspheres Sales (L) by Application (2021–2026)
Table 62. Global TACE Embolic Microspheres Sales (L) by Application (2027–2032)
Table 63. Global TACE Embolic Microspheres Sales Market Share by Application (2021–2026)
Table 64. Global TACE Embolic Microspheres Sales Market Share by Application (2027–2032)
Table 65. Global TACE Embolic Microspheres Revenue (US$ Million) by Application (2021–2026)
Table 66. Global TACE Embolic Microspheres Revenue (US$ Million) by Application (2027–2032)
Table 67. Global TACE Embolic Microspheres Revenue Market Share by Application (2021–2026)
Table 68. Global TACE Embolic Microspheres Revenue Market Share by Application (2027–2032)
Table 69. Global TACE Embolic Microspheres Price (US$/mL) by Application (2021–2026)
Table 70. Global TACE Embolic Microspheres Price (US$/mL) by Application (2027–2032)
Table 71. Boston Scientific Company Information
Table 72. Boston Scientific Description and Business Overview
Table 73. Boston Scientific TACE Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 74. Boston Scientific TACE Embolic Microspheres Product
Table 75. Boston Scientific Recent Developments/Updates
Table 76. Terumo Company Information
Table 77. Terumo Description and Business Overview
Table 78. Terumo TACE Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 79. Terumo TACE Embolic Microspheres Product
Table 80. Terumo Recent Developments/Updates
Table 81. Merit Medical Company Information
Table 82. Merit Medical Description and Business Overview
Table 83. Merit Medical TACE Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 84. Merit Medical TACE Embolic Microspheres Product
Table 85. Merit Medical Recent Developments/Updates
Table 86. Varian Company Information
Table 87. Varian Description and Business Overview
Table 88. Varian TACE Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 89. Varian TACE Embolic Microspheres Product
Table 90. Varian Recent Developments/Updates
Table 91. Sirtex Medical Company Information
Table 92. Sirtex Medical Description and Business Overview
Table 93. Sirtex Medical TACE Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 94. Sirtex Medical TACE Embolic Microspheres Product
Table 95. Sirtex Medical Recent Developments/Updates
Table 96. Suzhou Hengrui Medical Equipment Company Information
Table 97. Suzhou Hengrui Medical Equipment Description and Business Overview
Table 98. Suzhou Hengrui Medical Equipment TACE Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 99. Suzhou Hengrui Medical Equipment TACE Embolic Microspheres Product
Table 100. Suzhou Hengrui Medical Equipment Recent Developments/Updates
Table 101. ABK Biomedical Company Information
Table 102. ABK Biomedical Description and Business Overview
Table 103. ABK Biomedical TACE Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 104. ABK Biomedical TACE Embolic Microspheres Product
Table 105. ABK Biomedical Recent Developments/Updates
Table 106. Mermaid Medical Company Information
Table 107. Mermaid Medical Description and Business Overview
Table 108. Mermaid Medical TACE Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 109. Mermaid Medical TACE Embolic Microspheres Product
Table 110. Mermaid Medical Recent Developments/Updates
Table 111. Cardiolink Science Company Information
Table 112. Cardiolink Science Description and Business Overview
Table 113. Cardiolink Science TACE Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 114. Cardiolink Science TACE Embolic Microspheres Product
Table 115. Cardiolink Science Recent Developments/Updates
Table 116. Suzhou Haowei Medical Technology Company Information
Table 117. Suzhou Haowei Medical Technology Description and Business Overview
Table 118. Suzhou Haowei Medical Technology TACE Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
Table 119. Suzhou Haowei Medical Technology TACE Embolic Microspheres Product
Table 120. Suzhou Haowei Medical Technology Recent Developments/Updates
Table 121. Key Raw Materials Lists
Table 122. Raw Materials Key Suppliers Lists
Table 123. TACE Embolic Microspheres Distributors List
Table 124. TACE Embolic Microspheres Customers List
Table 125. TACE Embolic Microspheres Market Trends
Table 126. TACE Embolic Microspheres Market Drivers
Table 127. TACE Embolic Microspheres Market Challenges
Table 128. TACE Embolic Microspheres Market Restraints
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
Table 132. Authors List of This Report
List of Figures
Figure 1. Product Picture of TACE Embolic Microspheres
Figure 2. Global TACE Embolic Microspheres Market Value by Type (US$ Million), 2021–2032
Figure 3. Global TACE Embolic Microspheres Market Share by Type: 2025 & 2032
Figure 4. Common Embolic Microspheres Product Picture
Figure 5. Drug-Loadable Embolic Microspheres Product Picture
Figure 6. Global TACE Embolic Microspheres Market Value by Size (US$ Million), 2021–2032
Figure 7. Global TACE Embolic Microspheres Market Share by Size: 2025 vs 2032
Figure 8. 1G (<100μm) Product Picture
Figure 9. 2 G (≥100μm) Product Picture
Figure 10. Global TACE Embolic Microspheres Market Value by Application (US$ Million), 2021–2032
Figure 11. Global TACE Embolic Microspheres Market Share by Application: 2025 & 2032
Figure 12. Primary Liver Cancer
Figure 13. Colorectal Cancer Liver Metastasis
Figure 14. Others
Figure 15. Global TACE Embolic Microspheres Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global TACE Embolic Microspheres Market Size (US$ Million), 2021–2032
Figure 17. Global TACE Embolic Microspheres Sales (L), 2021–2032
Figure 18. Global TACE Embolic Microspheres Average Price (US$/mL), 2021–2032
Figure 19. TACE Embolic Microspheres Report Years Considered
Figure 20. TACE Embolic Microspheres Sales Share by Manufacturers in 2025
Figure 21. Global TACE Embolic Microspheres Revenue Share by Manufacturers in 2025
Figure 22. Top 5 and Top 10 Global TACE Embolic Microspheres Players: Market Share by Revenue in TACE Embolic Microspheres in 2025
Figure 23. TACE Embolic Microspheres Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 24. Global TACE Embolic Microspheres Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 25. North America TACE Embolic Microspheres Sales Market Share by Country (2021–2032)
Figure 26. North America TACE Embolic Microspheres Revenue Market Share by Country (2021–2032)
Figure 27. United States TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Canada TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Europe TACE Embolic Microspheres Sales Market Share by Country (2021–2032)
Figure 30. Europe TACE Embolic Microspheres Revenue Market Share by Country (2021–2032)
Figure 31. Germany TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. France TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. U.K. TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Italy TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Russia TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Asia Pacific TACE Embolic Microspheres Sales Market Share by Region (2021–2032)
Figure 37. Asia Pacific TACE Embolic Microspheres Revenue Market Share by Region (2021–2032)
Figure 38. China TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Japan TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. South Korea TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. India TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Australia TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. China Taiwan TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Southeast Asia TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Latin America TACE Embolic Microspheres Sales Market Share by Country (2021–2032)
Figure 46. Latin America TACE Embolic Microspheres Revenue Market Share by Country (2021–2032)
Figure 47. Mexico TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Brazil TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Argentina TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Colombia TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Middle East and Africa TACE Embolic Microspheres Sales Market Share by Country (2021–2032)
Figure 52. Middle East and Africa TACE Embolic Microspheres Revenue Market Share by Country (2021–2032)
Figure 53. Turkey TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Saudi Arabia TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. UAE TACE Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Global Sales Market Share of TACE Embolic Microspheres by Type (2021–2032)
Figure 57. Global Revenue Market Share of TACE Embolic Microspheres by Type (2021–2032)
Figure 58. Global TACE Embolic Microspheres Price (US$/mL) by Type (2021–2032)
Figure 59. Global Sales Market Share of TACE Embolic Microspheres by Application (2021–2032)
Figure 60. Global Revenue Market Share of TACE Embolic Microspheres by Application (2021–2032)
Figure 61. Global TACE Embolic Microspheres Price (US$/mL) by Application (2021–2032)
Figure 62. TACE Embolic Microspheres Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Trichosanthes Kirilowii Extract Market Research Report 2026
Feb 24, 26
Global Glass Lined Containers Market Research Report 2026
Feb 24, 26
Global Open End Wrenches Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232